KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Supernus Pharmaceuticals (SUPN) Preferred Dividend Payments: 2010-2012

Historic Preferred Dividend Payments for Supernus Pharmaceuticals (SUPN) over the last 3 years, with Dec 2012 value amounting to $1.1 million.

  • Supernus Pharmaceuticals' Preferred Dividend Payments fell 66.67% to $286,000 in Q2 2012 from the same period last year, while for Jun 2012 it was $2.9 million, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2012, which is 66.68% down from last year.
  • According to the latest figures from FY2012, Supernus Pharmaceuticals' Preferred Dividend Payments is $1.1 million, which was down 66.68% from $3.4 million recorded in FY2011.
  • Over the past 5 years, Supernus Pharmaceuticals' Preferred Dividend Payments peaked at $3.4 million during FY2010, and registered a low of $1.1 million during FY2012.
  • Its 3-year average for Preferred Dividend Payments is $2.7 million, with a median of $3.4 million in 2011.
  • Data for Supernus Pharmaceuticals' Preferred Dividend Payments shows a maximum YoY tumbled of 66.68% (in 2012) over the last 5 years.
  • Over the past 3 years, Supernus Pharmaceuticals' Preferred Dividend Payments (Yearly) stood at $3.4 million in 2010, then remained steady at $3.4 million in 2011, then slumped by 66.68% to $1.1 million in 2012.